ClinicaSpace Focus
   Thursday, February 04, 2010 Advertising Information
subscriptions careernetwork news hotbeds careerfairs
TOP SPONSOR

CHI's XGen Congress
March 15-19, 2010
San Diego, California
Website: www.xgencongress.com

Cambridge Healthtech Institute, the premier information provider for the life sciences industry, is proud to launch The XGEN CONGRESS, March 15-19, 2010 in San Diego, California. This week-long event features five conferences and demonstrates the unique cross fertilization of established genomic platforms with Now-Generation Sequencing and Quantitative PCR along with exciting applications of Copy Number Variation and Epigenetics. In addition, you will learn why data is the driving force that enables discovery at Sequencing Data Storage and Analysis. This week is strategically designed to allow in-depth coverage of applications and their supporting technological advances. Advance registration rates expire Friday, February 5.

Register Now to reserve your place and take advantage of the savings.
HeadHtml
•  US FDA Warns Eli Lilly and Company (LLY), Sanofi-Aventis (France) (SASY.PA), Meda AB (MDABF.PK) on Misleading Promotions More...
•  Alkermes (ALKS) Unveils Long-Acting Injectable Proprietary Platform for Treatment of Schizophrenia and Other CNS Disorders More...
•  Launch of Ipsen's Decapeptyl(R) 6-Month Formulation (LP 22.5 mg) in France for the Treatment of Locally Advanced or Metastatic Hormone-Dependent Prostate Cancer More...
•  Merz Pharma Canada Ltd. is Proud to Announce That Xeomin(R) has Received Exception Drug Status From the Conseil du medicament du Quebec(i) More...

More Drug Product News
HeadHtml
•  BTG plc (BGC.L) Receives First European Regulatory Approval for DigiFab(TM) More...

More Drug Approval News
HeadHtml
•  XenoPort, Inc. (XNPT) Announces Horizant(TM) as Brand Name for XP13512 More...

More PDUFA News
HeadHtml
•  Lux Biosciences Files for LUVENIQ(TM) Approval in US and Europe for Noninfectious Uveitis More...
•  Paladin Labs Inc. (CC:PLB) Granted Priority Review Status for Abstral(R) by Health Canada More...

More BLA/NDA/ANDA News
More IND News
More MAA News
HeadHtml
•  Protalix Biotherapeutics Announces Presentation of Phase III Taliglucerase Alfa Data at WORLD Lysosomal Disease Network More...
•  ArQule, Inc. (ARQL) Announces Initiation of Clinical Programs with ARQ 197 in Germ Cell Tumors and Colorectal Cancer More...
•  Health Decisions Exceeds Goals for Universal Flu Vaccine Study More...
•  Paloma Pharmaceuticals, Inc. Receives Approval to Enter Phase I Clinical Trials More...
•  AVI BioPharma, Inc. (AVII) GLP Safety Pharmacology and Genotoxicity Evaluations of AVI-4658 for Duchenne Muscular Dystrophy Published in the International Journal of Toxicology More...

More Phase III News
More Phase II News
More Phase I News
More Pre-Clinical News
More Post-Approval News
HeadHtml
•  The Scripps Research Institute Scientists Find Potential New Way to Enhance Vaccines More...
•  Male Erectile Dysfunction Drug Enhances Fetal Growth in Female Sheep, Texas AgriLife Research Study Finds More...
•  New Class of AIDS Drug? Two Compounds Lay Foundation, Help Combat Drug-Resistant Virus Strains, The Scripps Research Institute Study More...
•  Promising Results Shown For Kidney Cancer Drug, Temple University Study More...
•  Novel Compound Blocks Many Viruses, University of California, Los Angeles (UCLA) Study More...

More General Clinical Research News
Events
23rd Annual DIA Conference for Electronic Document Management: Global Content Management in an Electronic World

Join Biomedical Systems, a global leader in centralized diagnostic services for clinical trials, for a one day interactive workshop with a panel of international experts in the field of cardiac safety. The panel will be discussing issues related to the most optimal study design for safely developing Diabetes and Oncology compounds.

Please click here for more information
Latest Market Insight
Stakeholder Insight: Cancer Pain - Physician Survey Highlights Inadequacies in Education and Treatment

• Snapshot of the cancer pain market based on a survey of 180 physicians, supplemented with interviews with seven key opinion leaders.
• Overview of cancer pain prevalence, including three cancer pain subtypes: neuropathic, non-neuropathic and breakthrough pain.
• Analysis of pharmacological treatment rates, first-line treatment trends at the class level and rate of progression to second-line treatment.
• Assessment of physician perception of three branded analgesics, satisfaction with available treatments and unmet needs.

Click Here for More Information



BioSpace Hot Talk Forums

SF/Bay Area Life Science Forum
Southern California Biosciences Forum
International Life Science Forum
Life Science Career Q and A Forum (Career Talk)

DIA

Top Jobs
Pharm Country (East Hanover, New Jersey)

Sunrise Systems, Inc.
Drug Supply Management Trial Manager
Plans, establishes, manages, monitors, and performs activities related to trial management, to support the drug development process (Phase I-IV), in cooperation with internal and external customers and partners in compliance with multinational regulations as well as company internal procedures and GxP requirements.

Biotech Bay (Mountain View, California)

VIVUS, Inc.
Senior Director, Clinical Operations
You will supervise operations staff and all activities related to execution of clinical studies and programs in accordance with company SOPs, FDA, and ICH guidelines and regulations. You are also accountable for the successful execution of, and timelines for, all VIVUS clinical trials and programs.

BioCapital (Frederick, Maryland)

SAIC-Frederick, Inc.
Physician III (Pathologist)
The Clinical Services Program's primary mission is to perform sequential studies of immune function in patients with cancer, AIDS, chronic granulomatous disease or other diseases associated with immunologic dysfunction. Integral to this work is the NCI's Office of Biorepositories and Biospecimen Research's (OBBR) efforts in establishing the Cancer Human Biobank (caHUB).

Biotech Beach (Irvine, California)

Allergan Inc.
Principal Clinical Supplies Management Specialist
Independently design and set up timely, efficient and effective supply chains typically of high complexity supporting Tier I and II programs; support the clinical supply chains for assigned programs, including forecasting, manufacturing, inventory, and distribution plans; and effective planning of clinical supplies to ensure timely study starts and ongoing re-supplies per subject enrollment plans.

Genetown (Cambridge, Massachusetts)

Novartis Vaccines & Diagnostics, Inc.
Clinical Research Associate (Field Monitor)
Perform all required activities to ensure appropriate monitoring of investigator sites and trial execution under the supervision of the COM or Sr. CRA. Primary person responsible for management of assigned sites, including acting as central point of communication between Novartis and Investigator sites.

BioMidwest (Brown Deer, Wisconsin)

Life Technologies
Engineer III, Clinical Diagnostics
Mechanical Engineer needed to conduct design, development, testing and field support of instrumentation for clinical diagnostics, primarily transplant diagnostics.

• Get Noticed! Add your resume to the BioSpace Career Center!
• See more than 5,000 job postings in the BioSpace Career Center!



2010 Pharm Country Career Fair

Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, and medical device companies in the Philadelphia/New Jersey region.

Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend.

Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, clinical data management, chemistry, regulatory affairs, and research.

Job seekers may register here.

Pharm Country Career Fair, Bridgewater, NJ, February 25, 2010
Biotech Bay Career Fair, South San Francisco, CA, March 9, 2010
Genetown Career Fair, Cambridge, MA, March 15, 2010

More information about BioSpace's Career Fairs

BioSpace White Paper
Biotech Career Fairs For Job Seekers 101: Control Your Experience
By June Salvati, BioSpace Director of Events and Corporate Services

HeadHtml
•  Fate Therapeutics Receives Allowance of First U.S. Patent for Induced Pluripotent Stem Cell Technology More...

More Patent News
Feature

Hot Company

Igenica, Inc.
849 Mitten Road, Suite 104
Burlingame, California 94010 U.S.A.
View Jobs

Igenica, Inc. is a discovery-stage biopharmaceutical company focused on the creation of breakthrough antibody-based therapeutics to address the unmet medical needs of cancer patients.

More Company Profiles
Contact Us

Join Us on Facebook for even more up to the minute news, jobs, and career fairs!

Send questions and comments to the ClinicaSpace NewsBeat Team Headquarters:
    ClinicaSpace
    9100 E. Panorama Drive, Suite 200
    Englewood Colorado 80112 U.S.A.
    Phone: 877-277-7585
    Fax: 732-528-3668
    ClinicaSpace
    90 New Montgomery Street, Suite 414
    San Francisco, California 94105 U.S.A.
    Phone: 877-277-7585
    Fax: 415-576-9217
Editor & Publisher:
    Rosemary Do
Editorial & Production Staff:
    AnnaLyn Aquino
    Suvarna Bhatt
    Lana Ho
    Matt Thwin
BioSpace.com - Life * Science * Community
Legal Notice
• ClinicaSpace is a registered trademark of BioSpace, Inc.
• Please distribute this e-cast freely.
• Credit any excerpts as follows:
Copyright 2010 ClinicaSpace http://www.clinicaspace.com
• While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes.
Subscribe/Unsubscribe
If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply join the ClinicaSpace Focus here.

Safely unsubscribe from ClinicaSpace.com e-mail at any time by managing your account here or by clicking on the "unsubscribe" link at the bottom of this newsletter.